BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16608973)

  • 1. Non-small cell lung cancer: early stages.
    Bria E; Ceribelli A; Trovò MG; Gelibter A; Gigante M; Calabrò E; Cuppone F; Cognetti F; Terzoli E; Pastorino U
    Ann Oncol; 2006 Mar; 17 Suppl 2():ii17-21. PubMed ID: 16608973
    [No Abstract]   [Full Text] [Related]  

  • 2. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC).
    Felip E; Stahel RA; Pavlidis N;
    Ann Oncol; 2005; 16 Suppl 1():i28-9. PubMed ID: 15888743
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent advances and future perspectives in the management of lung cancer.
    Krupnick AS; Kreisel D; Hope A; Bradley J; Govindan R; Meyers B
    Curr Probl Surg; 2005 Aug; 42(8):540-610. PubMed ID: 16087000
    [No Abstract]   [Full Text] [Related]  

  • 4. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC).
    ESMO.
    Ann Oncol; 2001 Aug; 12(8):1049-50. PubMed ID: 11583180
    [No Abstract]   [Full Text] [Related]  

  • 5. [Management of nonresectable non-small cell lung cancer. Recommendations of the American Society of Clinical Oncology (ASCO)].
    Bompas E; Freyer G; Trillet-Lenoir V
    Bull Cancer; 1998 Feb; 85(2):125-7. PubMed ID: 9752328
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-small cell lung cancer: issues in diagnosis, staging and treatment.
    Harwood KV
    Semin Oncol Nurs; 1987 Aug; 3(3):183-93. PubMed ID: 3039637
    [No Abstract]   [Full Text] [Related]  

  • 7. [35th Congress of the American Society of Clinical Oncology, Atlanta, USA, 15-18 May 1999. Non-small-cell lung tumors].
    Foggi P
    Clin Ter; 1999; 150(3):181-6. PubMed ID: 10528429
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-small-cell lung cancer: then and now.
    Schiller JH; Gandara DR; Goss GD; Vokes EE
    J Clin Oncol; 2013 Mar; 31(8):981-3. PubMed ID: 23401450
    [No Abstract]   [Full Text] [Related]  

  • 9. Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement.
    Lynch TJ; Bogart JA; Curran WJ; DeCamp MM; Gandara DR; Goss G; Henschke CI; Jett JR; Johnson BE; Kelly KL; Le Chevalier T; Mulshine JL; Scagliotti GV; Schiller JH; Shaw A; Thatcher N; Vokes EE; Wood DE; Hart C
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):4981s-4983s. PubMed ID: 16000599
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxicity of hypofractionated accelerated radiotherapy concurrent with chemotherapy for non-small cell carcinoma of the lung.
    Carruthers R; O'Rourke N; Mohammed N; Hicks J; Brisbane I
    Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):561-2. PubMed ID: 21676603
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoadjuvant Therapy in Non-Small Cell Lung Cancer.
    Zheng Y; Jaklitsch MT; Bueno R
    Surg Oncol Clin N Am; 2016 Jul; 25(3):567-84. PubMed ID: 27261916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of practice survey for nonsmall cell lung carcinoma in the U.S.
    Choy H; Shyr Y; Cmelak AJ; Mohr PJ; Johnson DH
    Cancer; 2000 Mar; 88(6):1336-46. PubMed ID: 10717614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced non-small cell lung cancer: current state of knowledge.
    ONS News; 2004; 19(9 Suppl):41-2. PubMed ID: 15478581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally advanced non-small cell lung cancer: different strategies for different diseases.
    Antonelli G; Priolo D; Vitale F; Ferraù F
    Ann Oncol; 2006 Mar; 17 Suppl 2():ii24-27. PubMed ID: 16608975
    [No Abstract]   [Full Text] [Related]  

  • 15. Early-stage non-small-cell lung cancer: adjuvant versus neoadjuvant chemotherapy.
    Belani CP
    Clin Lung Cancer; 2003 Jul; 5(1):11-2. PubMed ID: 14596696
    [No Abstract]   [Full Text] [Related]  

  • 16. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Peters S; Adjei AA; Gridelli C; Reck M; Kerr K; Felip E;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii56-64. PubMed ID: 22997455
    [No Abstract]   [Full Text] [Related]  

  • 17. The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancer.
    Belani CP
    Clin Lung Cancer; 2005 May; 6(6):331-2. PubMed ID: 15943890
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of inoperable patients with non-small-cell lung cancer.
    Feld R
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Dec; 32 Suppl():19-24. PubMed ID: 7602831
    [No Abstract]   [Full Text] [Related]  

  • 19. Perioperative considerations for neoadjuvant immunotherapy in non-small cell lung cancer.
    Stiles BM; Sepesi B; Broderick SR; Bott MJ
    J Thorac Cardiovasc Surg; 2020 Nov; 160(5):1376-1382. PubMed ID: 32763029
    [No Abstract]   [Full Text] [Related]  

  • 20. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    D'Addario G; Früh M; Reck M; Baumann P; Klepetko W; Felip E;
    Ann Oncol; 2010 May; 21 Suppl 5():v116-9. PubMed ID: 20555059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.